Status:
COMPLETED
Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Urinary Incontinence, Stress
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purposes of this study are to determine whether duloxetine can help subjects with stress urinary incontinence and to see whether the effects of duloxetine can be maintained.
Eligibility Criteria
Inclusion
- Female diagnosed with stress urinary incontinence
Exclusion
- Currently taking a monoamine oxidase inhibitor
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
2765 Patients enrolled
Trial Details
Trial ID
NCT00190996
Start Date
January 1 2003
End Date
June 1 2006
Last Update
January 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Surrey, United Kingdom, KT24 6QT